Cancer Disease Natural Treatment

Scientists from the TGen and other research facilities and universities have identified a gene that may be linked to an aggressive form of prostate cancer, a finding that researchers say may advance the treatment of the disease. The scientists believe the gene, called DAB2IP, aids in suppressing tumor growth. When the gene takes on a variant form, the body's natural protection is stripped away, allowing prostate cancer to spread more rapidly, researchers say. Scientists say the research eventually could yield a simple blood test that helps doctors and patients determine the best course of treatment for the disease. .

TGen finds key prostate cancer gene

Scientists from TGen and other research facilities and universities have identified a gene that may be linked to an aggressive form of prostate cancer, a finding that researchers say could advance the treatment of the disease. The research eventually could yield a simple blood test to help doctors and patients determine the best course of treatment for the disease, scientists say. That would be an important step because physicians now have no way of knowing whether a prostate tumor is dangerous, prompting many unnecessary radiation treatments and surgeries that can have harmful side effects. The scientists believe the gene, called DAB2IP, aids in suppressing tumor growth. When the gene takes on a variant form, the body's natural protection is stripped away, allowing prostate cancer to spread unchecked, researchers say.

TGen team, other researchers find genetic clues to prostate cancer

Scientists from the TGen and other research facilities and universities have identified a gene that may be linked to an aggressive form of prostate cancer, a finding that researchers say may advance the treatment of the disease. The scientists believe the gene, called DAB2IP, aids in suppressing tumor growth. When the gene takes on a variant form, the body's natural protection is stripped away, allowing prostate cancer to spread more rapidly, researchers say. Scientists say the research eventually could yield a simple blood test that helps doctors and patients determine the best course of treatment for the disease. .

Mhlongo's love T.K.O

'They boxed me with their love!' exclaimed Busi Mhlongo immediately after a recent benefit concert in her honour. CRAIG CANAVAN was there to chat to the legendary Urban Zulu in the euphoric aftermath.

Far too often, benefit and tribute-style shows tend to be slapdash affairs, thrown together at the last minute with little forethought or care. Not usually the kind of concert any artist worthy of the name would want to be associated with. Not so, the recent glitzy, glam and quite glorious tribute concert for Busi Mhlongo organised by the SABC. The occasion was both happy and sad – Mhlongo celebrated her 60th birthday on October 28, in the midst of a battle against breast cancer. But the amount of care, thought and pure passion that went in to putting on the inaugural Vuka Sizwe Benefit Concert, held on the final weekend in October in Johannesburg (and broadcast live on SABC 2) had to be witnessed to be believed.

Roads to recovery: Vermonters share their story

Illness and injury can be devastating, life threatening and debilitating. For many, the road to recovery is paved with fear and uncertainty, while others find a way to push through. What fuels an individual�s recovery and shapes their story?

Dr. Terry Rabinowitz, a psychiatrist Fletcher Allen Health Care in Burlington, said biology and environment are factors.

�You have to look at each person as an individual ... not with the expectation that some who can�t recover or get the zest back are failures versus those who do would be considered successes,� Rabinowitz said. �You need to consider those two major components that make one more or less resilient ... Biologically, that�s who they are. The other stuff is just a consequence.�

Individuals recover in as many ways as they are unique: meditation, religion, work, yoga, exercise, hobbies, reading and more.

Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R ...

SUNNYVALE, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Accuray Incorporated (NASDAQ: ARAY) , a global leader in the field of radiosurgery, today announced that its CyberKnife(R) Robotic Radiosurgery System has been used to treat more than 4,000 lung cancer patients worldwide. The company also reported that more than 40,000 patients in total have been treated with CyberKnife radiosurgery for tumors throughout the body.

This significant growth is due in part to the increasing availability of Accuray's unparalleled lung cancer treatment offerings at CyberKnife centers.